{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T17:09:03Z","timestamp":1787504943019,"version":"build-2736575974"},"reference-count":56,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2016,7,16]],"date-time":"2016-07-16T00:00:00Z","timestamp":1468627200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["TL1TR001428"],"award-info":[{"award-number":["TL1TR001428"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UL1TR001427"],"award-info":[{"award-number":["UL1TR001427"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Specific isoforms from the carbonic anhydrase (CA) family of zinc metalloenzymes have been associated with a variety of diseases. Isoform-specific carbonic anhydrase inhibitors (CAIs) are therefore a major focus of attention for specific disease treatments. Classical CAIs, primarily sulfonamide-based compounds and their bioisosteres, are examined as antiglaucoma, antiepileptic, antiobesity, antineuropathic pain and anticancer compounds. However, many sulfonamide compounds inhibit all CA isoforms nonspecifically, diluting drug effectiveness and causing undesired side effects due to off-target inhibition. In addition, a small but significant percentage of the general population cannot be treated with sulfonamide-based compounds due to a sulfa allergy. Therefore, CAIs must be developed that are not only isoform specific, but also non-classical, i.e. not based on sulfonamides, sulfamates, or sulfamides. This review covers the classes of non-classical CAIs and the recent advances in the development of isoform-specific inhibitors based on phenols, polyamines, coumarins and their derivatives.<\/jats:p>","DOI":"10.3390\/ijms17071150","type":"journal-article","created":{"date-parts":[[2016,7,18]],"date-time":"2016-07-18T09:38:03Z","timestamp":1468834683000},"page":"1150","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":120,"title":["Non-Classical Inhibition of Carbonic Anhydrase"],"prefix":"10.3390","volume":"17","author":[{"given":"Carrie","family":"Lomelino","sequence":"first","affiliation":[{"name":"Department of Biochemistry and Molecular Biology, University of Florida, Gainesville, FL 32611, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4262-0323","authenticated-orcid":false,"given":"Claudiu","family":"Supuran","sequence":"additional","affiliation":[{"name":"Neurofarba Department, University of Florence, Piazza di San Marco, Firenze 50019, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"McKenna","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Biology, University of Florida, Gainesville, FL 32611, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2016,7,16]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0163-7258(96)00198-2","article-title":"Structure and mechanism of carbonic anhydrase","volume":"74","author":"Lindskog","year":"1997","journal-title":"Pharmacol. Ther."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1073\/pnas.72.1.51","article-title":"Crystal structure of human erythrocyte carbonic anhydrase B: Three-dimensional structure at a nominal 2.2-A resolution","volume":"72","author":"Kannan","year":"1975","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"3467","DOI":"10.1016\/j.bmcl.2010.05.009","article-title":"Carbonic anhydrase inhibitors","volume":"20","author":"Supuran","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nrd2467","article-title":"Carbonic anhydrases: Novel therapeutic applications for inhibitors and activators","volume":"7","author":"Supuran","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/med.10025","article-title":"Carbonic anhydrase inhibitors","volume":"23","author":"Supuran","year":"2003","journal-title":"Med. Res. Rev."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Frost, S.C., and McKenna, R. (2014). Carbonic Anhydrase: Mechanism, Regulation, Links to Disease, and Industrial Applications, Springer Science & Business Media.","DOI":"10.1007\/978-94-007-7359-2"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1016\/j.bmc.2012.04.044","article-title":"Structure, function and applications of carbonic anhydrase isozymes","volume":"21","author":"Shajee","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1107\/S2052252514004096","article-title":"Structural insight into activity enhancement and inhibition of H64A carbonic anhydrase II by imidazoles","volume":"1","author":"Aggarwal","year":"2014","journal-title":"IUCrJ"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1021\/ar00145a005","article-title":"The catalytic mechanism of carbonic anhydrase: Implications of a rate-limiting protolysis of water","volume":"21","author":"Silverman","year":"1988","journal-title":"Acc. Chem. Res."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1021\/bi0480279","article-title":"Structural and kinetic characterization of active-site histidine as a proton shuttle in catalysis by human carbonic anhydrase II","volume":"44","author":"Fisher","year":"2005","journal-title":"Biochemistry"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1021\/bi002295z","article-title":"Structural and kinetic analysis of the chemical rescue of the proton transfer function of carbonic anhydrase II","volume":"40","author":"Duda","year":"2001","journal-title":"Biochemistry"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1152\/physrev.1967.47.4.595","article-title":"Carbonic anhydrase: Chemistry, physiology, and inhibition","volume":"47","author":"Maren","year":"1967","journal-title":"Physiol. Rev."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S1350-9462(99)00006-3","article-title":"Pharmacological and ocular hypotensive properties of topical carbonic anhydrase inhibitors","volume":"19","author":"Sugrue","year":"2000","journal-title":"Prog. Retin. Eye Res."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.pain.2009.11.015","article-title":"Acetazolamide and midazolam act synergistically to inhibit neuropathic pain","volume":"148","author":"Asiedu","year":"2010","journal-title":"Pain"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1016\/j.bmc.2015.02.027","article-title":"A class of sulfonamide carbonic anhydrase inhibitors with neuropathic pain modulating effects","volume":"23","author":"Carta","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.bmc.2009.11.021","article-title":"Carbonic anhydrase inhibitors: Identification of selective inhibitors of the human mitochondrial isozymes VA and VB over the cytosolic isozymes I and II from a natural product-based phenolic library","volume":"18","author":"Davis","year":"2010","journal-title":"Bioorg. Med. Chem."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"5703","DOI":"10.1016\/j.bmcl.2004.07.085","article-title":"Carbonic anhydrase inhibitors: Inhibition of human cytosolic isozyme II and mitochondrial isozyme V with a series of benzene sulfonamide derivatives","volume":"14","author":"Innocenti","year":"2004","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"15789","DOI":"10.1074\/jbc.M110.188524","article-title":"Catalysis and pH control by membrane-associated carbonic anhydrase IX in MDA-MB-231 breast cancer cells","volume":"286","author":"Li","year":"2011","journal-title":"J. Biol. Chem."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.bbapap.2009.07.027","article-title":"Carbonic anhydrase IX: Biochemical and crystallographic characterization of a novel antitumor target","volume":"1804","author":"Supuran","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"9623","DOI":"10.1021\/jm401163e","article-title":"A prodrug approach toward cancer-related carbonic anhydrase inhibition","volume":"56","author":"Carroux","year":"2013","journal-title":"J. Med. Chem."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1038\/emboj.2013.160","article-title":"Neuronal carbonic anhydrase VII provides GABAergic excitatory drive to exacerbate febrile seizures","volume":"32","author":"Ruusuvuori","year":"2013","journal-title":"EMBO J."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1021\/jm0109199","article-title":"Carbonic anhydrase inhibitors: Anticonvulsant sulfonamides incorporating valproyl and other lipophilic moieties","volume":"45","author":"Masereel","year":"2002","journal-title":"J. Med. Chem."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1177\/1060028014534397","article-title":"Effect of long-term topiramate therapy on serum bicarbonate and potassium levels in adult epileptic patients","volume":"48","author":"Grabnar","year":"2014","journal-title":"Ann. Pharmacother."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1042\/BCJ20160115","article-title":"Structure and function of carbonic anhydrases","volume":"473","author":"Supuran","year":"2016","journal-title":"Biochem. J."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Supuran, C.T. (2015). How many carbonic anhydrase inhibition mechanisms exist?. J. Enzyme Inhib. Med. Chem., 1\u201316.","DOI":"10.1201\/9780203475300.ch1"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"6630","DOI":"10.1021\/acs.jmedchem.5b00845","article-title":"mapping selective inhibition of the cancer-related carbonic anhydrase IX using structure-activity relationships of glucosyl-based sulfamates","volume":"58","author":"Mahon","year":"2015","journal-title":"J. Med. Chem."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Pinard, M.A., Mahon, B., McKenna, R., Pinard, M.A., Mahon, B., and McKenna, R. (2015). Probing the surface of human carbonic anhydrase for clues towards the design of isoform specific inhibitors, probing the surface of human carbonic anhydrase for clues towards the design of isoform specific inhibitors. BioMed Res. Int., e453543.","DOI":"10.1155\/2015\/453543"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1016\/j.bmc.2012.08.019","article-title":"Insights towards sulfonamide drug specificity in \u03b1-carbonic anhydrases","volume":"21","author":"Aggarwal","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.bmc.2013.11.016","article-title":"Combining the tail and the ring approaches for obtaining potent and isoform-selective carbonic anhydrase inhibitors: Solution and X-ray crystallographic studies","volume":"22","author":"Bozdag","year":"2014","journal-title":"Bioorg. Med. Chem."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"7108","DOI":"10.1039\/C5CC01854D","article-title":"X-ray crystallography-promoted drug design of carbonic anhydrase inhibitors","volume":"51","author":"Ivanova","year":"2015","journal-title":"Chem. Commun. Camb. Engl."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.2146\/ajhp120291","article-title":"Sulfonamide cross-reactivity: Is there evidence to support broad cross-allergenicity?","volume":"70","author":"Wulf","year":"2013","journal-title":"Am. J. Health Syst. Pharm."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"778.e1","DOI":"10.1016\/j.amjmed.2009.01.034","article-title":"Self-reported antibiotic allergy incidence and prevalence: Age and sex effects","volume":"122","author":"Macy","year":"2009","journal-title":"Am. J. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1089\/ham.2010.1051","article-title":"Acetazolamide and sulfonamide allergy: A not so simple story","volume":"11","author":"Kelly","year":"2010","journal-title":"High Alt. Med. Biol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1016\/S0006-291X(82)80063-6","article-title":"Phenol, a competitive inhibitor of CO2 hydration catalyzed by carbonic anhydrase","volume":"108","author":"Simonsson","year":"1982","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"3659","DOI":"10.1021\/ja00087a086","article-title":"Two-site binding of phenol in the active site of human carbonic anhydrase II: Structural implications for substrate association","volume":"116","author":"Nair","year":"1994","journal-title":"J. Am. Chem. Soc."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1016\/j.bmcl.2008.01.077","article-title":"Carbonic anhydrase inhibitors: Interactions of phenols with the 12 catalytically active mammalian isoforms (CA I\u2013XIV)","volume":"18","author":"Innocenti","year":"2008","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1016\/j.bmc.2010.01.076","article-title":"Carbonic anhydrase inhibitors: Inhibition of mammalian isoforms I\u2013XIV with a series of natural product polyphenols and phenolic acids","volume":"18","author":"Innocenti","year":"2010","journal-title":"Bioorg. Med. Chem."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"7181","DOI":"10.1016\/j.bmc.2015.10.014","article-title":"Inhibition of mammalian carbonic anhydrase isoforms I\u2013XIV with a series of phenolic acid esters","volume":"23","author":"Maresca","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"7219","DOI":"10.1016\/j.bmc.2015.10.018","article-title":"New natural product carbonic anhydrase inhibitors incorporating phenol moieties","volume":"23","author":"Karioti","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"5259","DOI":"10.1039\/c2cc32013d","article-title":"Nucleophile recognition as an alternative inhibition mode for benzoic acid based carbonic anhydrase inhibitors","volume":"48","author":"Martin","year":"2012","journal-title":"Chem. Commun. Camb. Engl."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"5511","DOI":"10.1021\/jm1003667","article-title":"Polyamines inhibit carbonic anhydrases by anchoring to the zinc-coordinated water molecule","volume":"53","author":"Carta","year":"2010","journal-title":"J. Med. Chem."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"374079","DOI":"10.1155\/2014\/374079","article-title":"Natural product polyamines that inhibit human carbonic anhydrases","volume":"2014","author":"Davis","year":"2014","journal-title":"BioMed Res. Int."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/chem.201503748","article-title":"Combined crystallographic and theoretical study explains the capability of carboxylic acids to adopt multiple binding modes in the active site of carbonic anhydrases","volume":"22","author":"Langella","year":"2016","journal-title":"Chem. Eur. J."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1021\/acs.jmedchem.5b01940","article-title":"Native state mass spectrometry, surface plasmon resonance, and X-ray crystallography correlate strongly as a fragment screening combination","volume":"59","author":"Woods","year":"2016","journal-title":"J. Med. Chem."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1039\/C4CC07320G","article-title":"Out of the active site binding pocket for carbonic anhydrase inhibitors","volume":"51","author":"Carradori","year":"2015","journal-title":"Chem. Commun. Camb. Engl."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"5801","DOI":"10.1016\/j.bmcl.2012.07.094","article-title":"Inhibition of \u03b1-class cytosolic human carbonic anhydrases I, II, IX and XII, and \u03b2-class fungal enzymes by carboxylic acids and their derivatives: New isoform-I selective nanomolar inhibitors","volume":"22","author":"Sechi","year":"2012","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"5185","DOI":"10.1016\/j.bmcl.2014.09.076","article-title":"Carbonic anhydrase inhibitory activity of sulfonamides and carboxylic acids incorporating cyclic imide scaffolds","volume":"24","author":"Ceruso","year":"2014","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.bmc.2015.11.034","article-title":"Inhibition of carbonic anhydrase isoforms I, II, IV, VII and XII with carboxylates and sulfonamides incorporating phthalimide\/phthalic anhydride scaffolds","volume":"24","author":"Ayyad","year":"2016","journal-title":"Bioorg. Med. Chem."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"3057","DOI":"10.1021\/ja809683v","article-title":"Non-zinc mediated inhibition of carbonic anhydrases: Coumarins are a new class of suicide inhibitors","volume":"131","author":"Maresca","year":"2009","journal-title":"J. Am. Chem. Soc."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1021\/jm901287j","article-title":"Deciphering the mechanism of carbonic anhydrase inhibition with coumarins and thiocoumarins","volume":"53","author":"Maresca","year":"2010","journal-title":"J. Med. Chem."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"6955","DOI":"10.1016\/j.bmc.2015.09.041","article-title":"Click-tailed coumarins with potent and selective inhibitory action against the tumor-associated carbonic anhydrases IX and XII","volume":"23","author":"Nocentini","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"8271","DOI":"10.1021\/jm200983e","article-title":"Glycosyl coumarin carbonic anhydrase IX and XII inhibitors strongly attenuate the growth of primary breast tumors","volume":"54","author":"Touisni","year":"2011","journal-title":"J. Med. Chem."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1021\/jm301625s","article-title":"Sulfocoumarins (1,2-benzoxathiine-2,2-dioxides): A class of potent and isoform-selective inhibitors of tumor-associated carbonic anhydrases","volume":"56","author":"Tars","year":"2013","journal-title":"J. Med. Chem."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"4502","DOI":"10.1016\/j.bmc.2013.05.032","article-title":"7-substituted-sulfocoumarins are isoform-selective, potent carbonic anhydrase II inhibitors","volume":"21","author":"Tanc","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1021\/acs.jmedchem.5b01720","article-title":"Thioxocoumarins show an alternative carbonic anhydrase inhibition mechanism compared to coumarins","volume":"59","author":"Ferraroni","year":"2016","journal-title":"J. Med. Chem."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"2822","DOI":"10.1016\/j.bmc.2010.03.026","article-title":"Nanoscale enzyme inhibitors: Fullerenes inhibit carbonic anhydrase by occluding the active site entrance","volume":"18","author":"Innocenti","year":"2010","journal-title":"Bioorg. Med. Chem."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/17\/7\/1150\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T19:26:18Z","timestamp":1760210778000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/17\/7\/1150"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,16]]},"references-count":56,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2016,7]]}},"alternative-id":["ijms17071150"],"URL":"https:\/\/doi.org\/10.3390\/ijms17071150","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,16]]}}}